冠状室腔系统的异常与阿尔茨海默病中的粉样β聚合有关
Seyyed Ali Hosseini1,2,3, Etienne Aumont1,2,3, Nesrine Rahmouni1,2,3
1Translational Neuroimaging Laboratory, McConnell Brain Imaging Centre, Montreal Neurological Institute Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|February 25, 2026
概括
放大的心室和胆脉与阿尔茨海默病 (AD) 的进展和粉样β (Aβ) 聚合有关. 这些变化与关键的AD生物标志物和认知衰退相关.
科学领域:
- 神经科学是一个神经科学.
- 生物标志物 生物标志物
- 衰老研究研究 衰老研究
背景情况:
- 在衰老和阿尔茨海默氏病 (AD) 中观察到胆道腹腔系统的扩大.
- 新出现的证据表明,这些解剖变化与大脑中的粉样β (Aβ) 聚合之间存在联系.
研究的目的:
- 为了研究阿尔茨海默病 (AD) 病理生理学与胆道腹腔系统的测量之间的关联.
- 评估整个AD连续性的这些关系,从早期衰老到晚期疾病.
主要方法:
- 在ADNI和TRIAD队列中使用正子发射断层扫描 (PET) 分析心室体积,胆管体体积和心室放射性.
- 使用线性模型和部分相关性来评估措施之间的关系.
- 对已确立的AD生物标志物进行了测试,测试了胆道心室系统测量的复合得分.
主要成果:
- 腹腔和胆脉复合体的体积增加,而腹腔放射性随着AD阶段的推进而减少.
- 这些测量的异常甚至存在于粉素阴性老年人中.
- 这些指标与粉胺-PET,-PET,脑脊液 (CSF) 和血p-tau异型,GFAP水平和认知功能有显著的相关性.
结论:
- 胆道 - 腹腔系统的变化是相互关联的.
- 这些变化增加了皮层中总体的粉样蛋白β (Aβ) 负担.
相关概念视频
Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
Amyloid Fibrils
6.8K
6.8K
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K


